Observationmodel-written summary

Cryopreserved embryo-derived shoots had similar amarogentin content to controls, at 4.72 ± 0.11 ug/mg.

A claim from Artificial Seed Production and Cryopreservation by Encapsulation Dehydration for Medicinal Herb of Himalayan Region, Swertia Chirayita · 2022

Observationobservedoriginal resultpositivemeasured

Claim · model-written summary

Cryopreserved embryo-derived shoots had similar amarogentin content to controls, at 4.72 ± 0.11 ug/mg.

Taxon
Swertia ChirayitaSwertia chirayitat0
Organ / stage
One month old in-vitro grown shootse0
Outcome
amarogentine0
Direction
similare0
Value
4.72 ± 0.11 ug/mge0
Comparator
control materiale0

Not reportedMaterialGeneCompoundInteractorInteractor roleSecond interactorSecond interactor roleTreatmentSettingQualifier

Organisms pictured · Representative pictures of the matched species, not figures from the paper.

Swertia chirayita
Swertia chirayita · Taxon · picture from its Wikimedia Commons categoryRison Thumboor from Thrissur, India · CC BY 2.0 · Wikimedia Commons ↗

Verbatim

e0

“One month old in-vitro grown shoots from cryopreserved somatic embryos had similar marker medicinal compounds, such as amarogentin (4.72 ± 0.11 ug/mg) and mangiferin (14.54 ± 0.05 ug/mg), as control material”

✓ located verbatim in the source · abstract, characters 1210–1417
t0

“Swertia Chirayita”

✓ located verbatim in the source · title, characters 117–134

Title

Artificial Seed Production and Cryopreservation by Encapsulation Dehydration for Medicinal Herb of Himalayan Region, Swertia Chirayita

Rolika Gupta; Hemant Sood Cryoletters 2022. doi:10.54680/fr22510110612

Other claims from this paper (5)

Record rev-3a20a647c2ecf7f0b03823daee9a2151ffb3703c57d5e2c051fa7ea626483ad6 · schema claims-v0.9 · position 4 in the model’s answer